9-Oct-2026
Newsfile (Thu, 8-Oct 4:10 PM ET)
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses
Newsfile (Tue, 6-Oct 6:25 PM ET)
Kaplan Fox Urges Investors of Cellebrite DI Ltd. (CLBT) with Losses to Contact the Firm
Newsfile (Fri, 2-Oct 2:15 PM ET)
Kaplan Fox Reminds Investors of Cellebrite DI Ltd. (CLBT) of an Ongoing Securities Investigation
Newsfile (Wed, 30-Sep 8:41 AM ET)
Newsfile (Mon, 28-Sep 8:06 AM ET)
Newsfile (Thu, 24-Sep 4:20 PM ET)
PRNewswire (Thu, 24-Sep 4:18 PM ET)
PRNewswire (Wed, 23-Sep 8:30 AM ET)
Kaplan Fox Notifies Investors of Cellebrite DI Ltd. (CLBT) of a Securities Law Investigation
Newsfile (Tue, 22-Sep 6:36 PM ET)
Newsfile (Fri, 18-Sep 9:05 AM ET)
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Cellebrite Di Ltd. - trades on the NASDAQ stock market under the symbol CLBT.
As of October 9, 2026, CLBT stock price declined to $11.26 with 1,310,382 million shares trading.
CLBT has a beta of 0.91, meaning it tends to be less sensitive to market movements. CLBT has a correlation of 0.03 to the broad based SPY ETF.
CLBT has a market cap of $2.70 billion. This is considered a Mid Cap stock.
Last quarter Cellebrite Di Ltd. - reported $131 million in Revenue and $.11 earnings per share. This fell short of revenue expectation by $-934,488 and met earnings estimates .
In the last 3 years, CLBT traded as high as $26.30 and as low as $6.37.
The top ETF exchange traded funds that CLBT belongs to (by Net Assets): IEFA, SCZ, WCLD, TMFG, EIS.
CLBT has underperformed the market in the last year with a price return of -40.7% while the SPY ETF gained +16.8%. CLBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.8% and -1.0%, respectively, while the SPY returned +4.7% and +1.5%, respectively.
CLBT support price is $11.07 and resistance is $11.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLBT shares will trade within this expected range on the day.
